Mesenchymal stem cells: ideal seeds for treating diseases

Area of Science:

• Stem Cell Biology
• Regenerative Medicine
• Immunology

Background:

• Mesenchymal stem cells (MSCs) possess multipotent stem cell characteristics, including self-renewal and multi-differentiation capabilities.
• MSCs exhibit significant immunomodulatory properties, positioning them as valuable therapeutic agents.
• Current clinical research extensively investigates MSC applications across various diseases.

Purpose of the Study:

• To explore the therapeutic potential of Mesenchymal stem cells (MSCs) in treating a range of diseases.
• To highlight the role of MSCs in managing autoimmune conditions like systemic lupus erythematosus and Crohn's disease.
• To investigate the potential application of MSCs in oncology, aging, and infectious diseases, including COVID-19.

Main Methods:

• Review of existing clinical trials and research on Mesenchymal stem cells (MSCs).
• Analysis of MSC mechanisms, including immunomodulation, anti-inflammation, and anti-apoptosis.
• Evaluation of MSC-mediated tissue and organ repair promotion.

Main Results:

• MSCs demonstrate efficacy in reducing inflammation and apoptosis in tissue cells.
• MSCs promote the proliferation of endogenous tissue and organ cells, facilitating repair.
• MSCs show promise for treating autoimmune diseases, cancer, aging, and infectious diseases like COVID-19.

Conclusions:

• Mesenchymal stem cells (MSCs) are practical stem cells with broad therapeutic applications.
• MSC-based therapies offer potential for tissue repair and treatment of inflammatory and autoimmune conditions.
• Further research into MSCs is warranted for their role in managing complex diseases such as COVID-19.